BBS-Bioactive Bone Substitutes Oyj (HEL: BONEH)

BONEH Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	2023	2022	2021	2020	2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-3.56	-3.48	-3.09	-2.77	-2.73	-1.64
Depreciation & Amortization	0.22	0.22	0.23	0.23	0.21	0.23
Other Operating Activities	0.04	0.04	0.02	0.07	0	-0
Change in Accounts Receivable	0.29	0.29	-0.05	-0.12	-0.07	-0.05
Change in Other Net Operating Assets	-0.06	0.01	0.08	0.08	0.17	0.02
Operating Cash Flow	-3.07	-2.92	-2.82	-2.52	-2.42	-1.44
Capital Expenditures	-	-	-0.08	-0.13	-0.08	-0.02
Investing Cash Flow	-	-	-0.08	-0.13	-0.08	-0.02
Long-Term Debt Issued	-	-	0.05	0.75	-	-
Total Debt Issued	0.5	-	0.05	0.75	-	-
Long-Term Debt Repaid	-	-0.5	-0.58	-0.31	-0.32	-0
Total Debt Repaid	-0.5	-0.5	-0.58	-0.31	-0.32	-0
Net Debt Issued (Repaid)	-0.01	-0.5	-0.53	0.44	-0.32	-0
Issuance of Common Stock	2.25	3.88	3.71	-	5.74	0.3
Other Financing Activities	-	-	-	-	0	-0
Financing Cash Flow	2.24	3.38	3.18	0.44	5.42	0.3
Miscellaneous Cash Flow Adjustments	-	-	-	-	-	0
Net Cash Flow	-0.82	0.45	0.28	-2.2	2.92	-1.17
Free Cash Flow	-3.07	-2.92	-2.89	-2.64	-2.5	-1.47
Free Cash Flow Per Share	-0.18	-0.24	-0.35	-0.40	-0.42	-0.29
Cash Interest Paid	0.16	0.09	0.13	0.14	0.09	0.1
Levered Free Cash Flow	-	-1.6	-1.78	-1.67	-1.65	-0.85
Unlevered Free Cash Flow	-	-1.53	-1.69	-1.55	-1.6	-0.79
Change in Net Working Capital	-	-0.36	-0.01	0.05	0.08	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.